Clinical Trial

Safety and Activity of HF50 in Patients With Advanced Solid Tumors

Name: Safety and Activity of HF50 in Patients With Advanced Solid Tumors — clinical trial record (NCT07601334)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A study to assess the safety, tolerability, and pharmacokinetics of HF50 in participants with advanced solid tumors.

Trial Details

NCT Number	NCT07601334
Lead Sponsor	HighField Biopharmaceuticals Corporation
Conditions	Advanced Solid Tumors
Enrollment	45 participants
Start Date	2026-06-30
Primary Completion	2028-06-30 (estimated)
Study Completion	2029-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-22